13-Feb-2026
Tilray Expands UK Pharmaceutical Access Through Strategic Agreement with Smartway Pharmaceuticals
Globe Newswire (Thu, 12-Feb 7:00 AM ET)
Cannabis rally fizzles as rescheduling hopes fade
Seeking Alpha News (Wed, 11-Feb 12:43 PM ET)
Breckenridge Distillery Appoints Romano Beverage for Distribution in Illinois
Globe Newswire (Wed, 4-Feb 8:00 AM ET)
Tilray's CC Pharma Recognized as a TOP 100 Innovator in Germany
Globe Newswire (Wed, 4-Feb 7:00 AM ET)
Tilray’s Game Day Push: Creative Taproom Events and Specials Signal Consumer-Focused Growth Strategy
Market Chameleon (Tue, 3-Feb 2:42 AM ET)
Globe Newswire (Tue, 3-Feb 7:00 AM ET)
Globe Newswire (Thu, 29-Jan 7:00 AM ET)
Globe Newswire (Tue, 27-Jan 7:00 AM ET)
SweetWater Unveils Big Trip Double IPA—Tilray Brands Targets Growth in High-ABV Craft Beer Market
Market Chameleon (Thu, 22-Jan 3:24 AM ET)
SweetWater Introduces Big Trip Double IPA: A Bold New Craft Beer
Globe Newswire (Thu, 22-Jan 7:00 AM ET)
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.
Tilray Brands trades on the NASDAQ stock market under the symbol TLRY.
As of February 13, 2026, TLRY stock price climbed to $7.51 with 2,877,604 million shares trading.
TLRY has a beta of 1.17, meaning it tends to be more sensitive to market movements. TLRY has a correlation of 0.03 to the broad based SPY ETF.
TLRY has a market cap of $874.97 million. This is considered a Small Cap stock.
Last quarter Tilray Brands reported $218 million in Revenue and $.01 earnings per share. This beat revenue expectation by $7 million and exceeded earnings estimates by $.07.
In the last 3 years, TLRY traded as high as $34.00 and as low as $3.51.
The top ETF exchange traded funds that TLRY belongs to (by Net Assets): MJ, VHT, ESML, SMLF, FHLC.
TLRY has underperformed the market in the last year with a return of -20.4%, while the SPY ETF gained +13.0%. In the last 3 month period, TLRY fell short of the market, returning -33.5%, while SPY returned +1.7%. However, in the most recent 2 weeks TLRY has outperformed the stock market by returning +0.7%, while SPY returned -1.5%.
TLRY support price is $7.20 and resistance is $7.78 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TLRY shares will trade within this expected range on the day.